Limerick-based Regneron expands Covid-19 drug treatment trials

The global clinical program has now been initiated in Italy, Spain, Germany, France, Canada, Russia and the United States.

Biotech company Regeneron, which has a major industrial operations centre in Limerick, has expanded trails of its arthritis drug as a possible treatment for Covid-19.

In a partnership with French drug company Sanofi, Regeneron has begun treating the first patient outside of the US as part of a global clinical program evaluating Kevzara in patients hospitalised with severe COVID-19.